Delivery Order SPE2DB22D3401-SPE2DB25FT5ZH
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Rectiv 0.4% Ointment in 30-gram units, with a ceiling value of $1,288.80. This is a firm fixed price delivery order with no set-aside designation, indicating it was competitively awarded. The order is set to complete by August 5, 2025, and will be performed at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. This delivery order is a child...
- The Defense Logistics Agency awarded a $5,040.88 delivery order contract to Amerisourcebergen Drug Corporation for the supply of 4561958976 Rectiv 0.4% Ointment 30gm. As the prime contractor, Amerisourcebergen Drug Corporation will deliver the specified pharmaceutical product to a location in Conshohocken, Pennsylvania under a firm fixed price contract structure. The single delivery is to be completed by August 29, 2023 to support the Defense Logistics Agency's medical supply chain programs....
- The U.S. Defense Logistics Agency (DLA) awarded a $10,120.82 Firm Fixed Price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide RECTIV 0.4% OINTMENT 30GM. This order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, which covers a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,062.14 firm fixed-price delivery order is for the supply of 4566134271 - RECTIV 0.4% OINTMENT 30GM, with a completion date of October 18, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
- The Defense Logistics Agency awarded a $5,425 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4562055038 RECTIV 0.4% Ointment 30gm. The single award was issued under an indefinite-delivery/indefinite-quantity contract vehicle to supply pharmaceutical products and services to DLA and the Department of Defense. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a period of one day, from September 5-6, 2023. No subcontractors or...
- The Defense Logistics Agency awarded a $8,899.78 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 4561377686 RECTIV 0.4% Ointment, 30gm. The single award delivery order was issued against an existing prime vendor contract vehicle and will be performed by Amerisourcebergen at its corporate office and distribution facility located in Conshohocken, Pennsylvania, with work scheduled for completion by June 30, 2023. No subcontractors or set aside designations...
- This is a federal contract award issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,042.82, is for the delivery of RECTIV 0.4% OINTMENT 30GM medical supplies. This is a Firm Fixed Price Delivery Order contract with an ultimate completion date of June 26, 2024. The contract was awarded on June 25, 2024 and has no set-aside designation, indicating open...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $2,528.97, is for the delivery of RECTIV 0.4% ointment in 30-gram quantities. The contract is a firm fixed-price, non-set-aside award with a period of performance through May 2, 2025. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00, which...
- This federal contract award is for the delivery of RECTIV 0.4% OINTMENT 30GM to the Defense Logistics Agency (DLA). The contract, valued at $4,692.01, was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order placed under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide RECTIV 0.4% ointment. This $7,587.34 award is part of a larger $999,999,999.00 indefinite delivery contract (IDC) with AmerisourceBergen Drug Corp to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department...
- SPE2DB22D3401Indefinite Delivery Contract
- SPE2DB22D3401-SPE2DB25FT5ZHDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $2,207.91 to AmerisourceBergen Drug Corp on September 4, 2025, for Rectiv 0.4% Ointment in 30-gram units. This is a firm fixed price delivery order with no set-aside designation, with an ultimate completion date of September 5, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion vehicle running through December 2026 that serves as a global pharmaceutical support mechanism for military healthcare systems. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, is a critical federal vendor for medical procurement supporting the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company holds a proven track record of competitively awarded, non-set-aside contracts with DLA for a comprehensive range of pharmaceutical products and medical supplies across multiple therapeutic domains. This award reflects the company's capability to fulfill federal medical supply requirements and supports the military healthcare supply chain's ongoing pharmaceutical needs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.2k | 9/4/25 |